Each copper peptide patch for skin and hair is infused with GHK-Cu, a clinically backed ingredient known to support collagen, elasticity, and hair strength
In 2025, the FDA placed several peptides into a limited category, stating they should not be used in compounded drugs due to potential risks
1 Adverse reactions that occurred in 2% of patients treated with RADICAVA and 2% more frequently in placebo-treated patients 1 Hypersensitivity reactions and cases of anaphylaxis have been reported in postmarketing reports with RADICAVA 1 Discontinuations were not associated with contusion, gait disturbance, or headache in patients treated with RADICAVA 2 No known drug interactions based on in vitro drug interaction studies 1 RADICAVA ORS Was Generally Well Tolerated 1,3 The safety profile of RADICAVA ORS was demonstrated in a 6-month, phase 3, open-label clinical trial in 185 patients
When GLP1s suppress appetite, the risk of unintended muscle loss is real unless resistance training and adequate protein intake are prioritized
Our team of skilled practitioners stays at the forefront of peptide research, continuously integrating the latest advancements into our practice
